BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.

SANTA BARBARA, CA, UNITED STATES, April 22, 2025 / EINPresswire.com / -- “Up to 12% of patients undergoing minimally invasive ...

China is witness a CAGR of 5.8% by 2035. Rising demand for painless recovery fuels growth in non-invasive surgical wound ...